Literature DB >> 25092795

Safe prescribing of physical health medication in patients with dementia.

Delia Bishara1, Daniel Harwood.   

Abstract

OBJECTIVE: The prescription of multiple medications for older people is common, despite concerns over the dangers associated with this. Older adults are particularly vulnerable to adverse effects of medication, and this is an even greater risk in patients with dementia. Many drugs used for physical health conditions can negatively affect cognition. Our aim was to identify areas of concern and which drugs to avoid in patients with dementia.
DESIGN: A review of the literature was carried out using Pubmed, Medline and Embase.
RESULTS: Many drugs used for physical health conditions may worsen the symptoms of dementia. They do this either by negating the effects of cognitive enhancers or through direct adverse effects on cognition
CONCLUSIONS: Where evidence exists, we provide guidance as to the safest drugs to prescribe in particular clinical situations. Anticholinergic drugs should be avoided in dementia wherever possible. Effective pain management is important in older patients, but caution should be used when selecting an opioid analgesic because of their adverse central effects. Cardiac drugs have overall negligible effects on cognition, although some have been reported to cause delirium.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cognition; dementia; medication

Mesh:

Substances:

Year:  2014        PMID: 25092795     DOI: 10.1002/gps.4163

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  3 in total

1.  DEL-FINE: a new tool for assessing the delirogenic properties of drugs of relevance for European pharmacotherapy.

Authors:  Birgit Böhmdorfer; Sonja Rohleder; Martin Wawruch; T J M van der Cammen; Thomas Frühwald; Christian Jagsch; Susanne Melitta Maria Janowitz; Marietta Nagano; Mirko Petrovic; Ulrike Sommeregger; Bernhard Iglseder
Journal:  Z Gerontol Geriatr       Date:  2015-08-19       Impact factor: 1.281

2.  Aspirin in people with dementia, long-term benefits, and harms: a systematic review.

Authors:  Katrina A S Davis; Delia Bishara; Mariam Molokhia; Christoph Mueller; Gayan Perera; Robert J Stewart
Journal:  Eur J Clin Pharmacol       Date:  2021-01-22       Impact factor: 2.953

3.  Exploring pathways to Hospital Care for Patients with Alzheimer's disease and related dementias in rural South Western Uganda.

Authors:  Nathan Kakongi; Godfrey Zari Rukundo; Bizu Gelaye; Edith K Wakida; Celestino Obua; Elialilia S Okello
Journal:  BMC Health Serv Res       Date:  2020-06-03       Impact factor: 2.908

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.